Clinical Trial Update: AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

View source ↗

Summary

ClinicalTrials.gov entry for the AVAIL study—a non-alcoholic fatty liver disease biobank and registry sponsored by AdventHealth Translational Research Institute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Non-Alcoholic Fatty Liver Disease | Status: RECRUITING